NO991733L - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733L
NO991733L NO991733A NO991733A NO991733L NO 991733 L NO991733 L NO 991733L NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 L NO991733 L NO 991733L
Authority
NO
Norway
Prior art keywords
preparation
igm
intravenous administration
immunoglobulin
protease
Prior art date
Application number
NO991733A
Other languages
English (en)
Norwegian (no)
Other versions
NO991733D0 (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (2)

Publication Number Publication Date
NO991733D0 NO991733D0 (no) 1999-04-13
NO991733L true NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (zh)
EP (1) EP0835880A1 (zh)
JP (1) JP2001504092A (zh)
KR (1) KR20000048826A (zh)
CN (1) CN1233258A (zh)
AU (1) AU725134B2 (zh)
BR (1) BR9712306A (zh)
CA (1) CA2266848A1 (zh)
CZ (1) CZ125599A3 (zh)
HU (1) HUP0001069A3 (zh)
ID (1) ID21364A (zh)
IL (1) IL129383A0 (zh)
NO (1) NO991733L (zh)
NZ (1) NZ334885A (zh)
PL (1) PL332774A1 (zh)
RU (1) RU2191032C2 (zh)
SI (1) SI9720063A (zh)
SK (1) SK46699A3 (zh)
WO (1) WO1998016558A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
AU2004256354B2 (en) * 2003-07-15 2011-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
US7803914B2 (en) 2003-10-09 2010-09-28 Chugai Seiyaku Kabushiki Kaisha Methods for stabilizing protein solutions
WO2005035574A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha IgM高濃度安定化溶液
EP1981540B1 (en) * 2006-01-30 2013-03-20 Grifols Therapeutics Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
AU2009246510B2 (en) * 2008-05-12 2014-02-13 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
CN106456763B (zh) 2014-06-03 2018-03-13 埃克斯生物科技公司 用于治疗和预防金黄色葡萄球菌感染的组合物和方法
CA3183021A1 (en) * 2020-07-10 2022-01-13 Myles Lindsay Method for obtaining a composition comprising human plasma-derived immunoglobulin m

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (zh) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
AU725134B2 (en) 2000-10-05
JP2001504092A (ja) 2001-03-27
NO991733D0 (no) 1999-04-13
SI9720063A (sl) 1999-08-31
WO1998016558A1 (de) 1998-04-23
EP0835880A1 (de) 1998-04-15
HUP0001069A2 (hu) 2000-10-28
CZ125599A3 (cs) 1999-07-14
CN1233258A (zh) 1999-10-27
NZ334885A (en) 2000-09-29
AU4449597A (en) 1998-05-11
ID21364A (id) 1999-05-27
IL129383A0 (en) 2000-02-17
KR20000048826A (ko) 2000-07-25
PL332774A1 (en) 1999-10-11
RU2191032C2 (ru) 2002-10-20
US6136312A (en) 2000-10-24
SK46699A3 (en) 2000-06-12
BR9712306A (pt) 1999-08-31
HUP0001069A3 (en) 2000-12-28
CA2266848A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
NO991733L (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
ATE155043T1 (de) Behandlung von autoimmun- und entzundungskrankheiten
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DE59305092D1 (de) Haarnachbehandlungsmittel
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
ATE230605T1 (de) Wundheilmittel und behandlung von fibrotischen storungen durch tgfbeta-3
FI935585A0 (fi) Pyrrolopyrimidiner
DE69229275T2 (de) Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
DE69333626D1 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE69233012T2 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
DE59105609D1 (de) Verwendung von anti-TNF-Antikörpern als Arzneimittel bei der Behandlung von Ischämien und deren Folgen.
DK132284D0 (da) Immunoglobulin-g-holdig fraktion
ATE117900T1 (de) Verfahren zur herstellung nicht modifizierter intravenös verabreichbarer igm- und/oder iga- haltige immunglobulinpräparate.
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
EP0733361A3 (en) Method for inactivating enveloped viruses and sperm
MA23364A1 (fr) Associations d'un fongicide a groupe azole avec un insecticide a groupe pyrazole, pyrrole ou phenylimidazole.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
ZA94333B (en) Synergistic combination of compound having an antogonist effect on NK1 and on NK2 receptors
NO890046D0 (no) Disubstituerte pyridiner.
ATE37182T1 (de) Imidazolinone und imidazolidinthione, verfahren zu deren herstellung und verwendung dieser verbindungen als herbizide.
DE68906551T2 (de) Azolsubstituierte cycloalkanol-derivate, verfahren zu deren herstellung und anwendung dieser derivate als fungizide in der landwirtschaft und im gartenbau.
DK0493446T3 (da) Behandling af autoimmunsygdom.
KR890009389A (ko) 바이러스를 억제시키는 방법
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application